Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 11Recruiting 6Not yet recruiting 4Withdrawn 2Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 20Rectal Neoplasms 12Colonic Neoplasms 11Head and Neck Neoplasms 6Neoplasm Metastasis 5Carcinoma, Hepatocellular 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Neoplasms 3Keratosis, Actinic 3Esophageal Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Skin Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Nasopharyngeal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Tongue Neoplasms 1Recurrence 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, Non-Hodgkin 1

Interventions

Gemcitabine 3Cisplatin 3Irinotecan 2Fluorouracil 2Capecitabine 2tremelimumab 1pamiparib 1durvalumab 1brigimadlin 1atezolizumab 1Temozolomide 1Surgical Procedures, Operative 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Leucovorin 1IMC-001 1Blood Specimen Collection 1ARX788 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Biliary Tract Neoplasms × Fluorouracil × Clear all
NCT03110510 2022-06-15

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Samsung Medical Center

Phase 2 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms

NCT04480190 2022-04-20

Neoadjuvant Therapy in Biliary Adenocarcinoma

University of Cincinnati

Phase 1 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡